# Methotrexate in Ankylosing Spondylitis (MTX in AS)

> **NCT00243750** · PHASE2 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 20 (—)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00243750
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 20 (—)
- **Last updated:** 2005-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00243750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00243750, "Methotrexate in Ankylosing Spondylitis (MTX in AS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00243750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*